Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Upregulation of soluble and membrane-bound human leukocyte antigen G expression is primarily observed in the milder histopathological stages of chronic hepatitis C virus infection.

de Oliveira Crispim JC, Silva TG, Souto FJ, Souza FF, Bassi CL, Soares CP, Zucoloto S, Moreau P, Martinelli Ade L, Donadi EA.

Hum Immunol. 2012 Mar;73(3):258-62. doi: 10.1016/j.humimm.2011.12.004. Epub 2011 Dec 8.

PMID:
22178697
2.

Elevation of plasma soluble human leukocyte antigen-G in patients with chronic hepatitis C virus infection.

Weng PJ, Fu YM, Ding SX, Xu DP, Lin A, Yan WH.

Hum Immunol. 2011 May;72(5):406-11. doi: 10.1016/j.humimm.2011.02.008. Epub 2011 Mar 4.

PMID:
21377504
3.

KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.

Marangon AV, Silva GF, de Moraes CF, Grotto RM, Pardini MI, de Pauli DS, Sell AM, Visentainer JE, Moliterno RA.

Hum Immunol. 2011 Nov;72(11):1074-8. doi: 10.1016/j.humimm.2011.08.017. Epub 2011 Aug 28.

PMID:
21920398
4.

Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis.

Amiot L, Vu N, Rauch M, L'Helgoualc'h A, Chalmel F, Gascan H, Turlin B, Guyader D, Samson M.

J Hepatol. 2014 Feb;60(2):245-52. doi: 10.1016/j.jhep.2013.09.006. Epub 2013 Sep 12.

5.

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.

Liver Transpl. 2009 Apr;15(4):390-9. doi: 10.1002/lt.21673.

6.

Liver HLA-G expression is associated with multiple clinical and histopathological forms of chronic hepatitis B virus infection.

Souto FJ, Crispim JC, Ferreira SC, da Silva AS, Bassi CL, Soares CP, Zucoloto S, Rouas-Freiss N, Moreau P, Martinelli AL, Donadi EA.

J Viral Hepat. 2011 Feb;18(2):102-5. doi: 10.1111/j.1365-2893.2010.01286.x.

PMID:
20236238
7.

Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni.

Kamal S, Madwar M, Bianchi L, Tawil AE, Fawzy R, Peters T, Rasenack JW.

Liver. 2000 Jul;20(4):281-9.

PMID:
10959806
8.

Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients.

Adinolfi LE, Utili R, Andreana A, Tripodi MF, Rosario P, Mormone G, Ragone E, Pasquale G, Ruggiero G.

Eur J Gastroenterol Hepatol. 2000 Mar;12(3):299-304.

PMID:
10750650
9.

Clinicopathological features and genotype distribution in patients with hepatitis C virus chronic liver disease.

Abraham R, Ramakrishna B, Balekuduru A, Daniel HD, Abraham P, Eapen CE, Kurian G.

Indian J Gastroenterol. 2009 Mar-Apr;28(2):53-8. doi: 10.1007/s12664-009-0018-z. Epub 2009 Aug 21.

PMID:
19696989
11.

Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis.

Sreenarasimhaiah J, Jaramillo A, Crippin J, Lisker-Melman M, Chapman WC, Mohanakumar T.

Hum Immunol. 2003 Feb;64(2):224-30.

PMID:
12559624
12.

Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.

Abel M, Sène D, Pol S, Bourlière M, Poynard T, Charlotte F, Cacoub P, Caillat-Zucman S.

Hepatology. 2006 Dec;44(6):1607-16.

PMID:
17133491
13.

Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.

Penna A, Missale G, Lamonaca V, Pilli M, Mori C, Zanelli P, Cavalli A, Elia G, Ferrari C.

Hepatology. 2002 May;35(5):1225-36.

PMID:
11981773
14.

Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.

López-Labrador FX, He XS, Berenguer M, Cheung RC, González-Candelas F, Wright TL, Greenberg HB.

J Med Virol. 2004 Apr;72(4):575-85.

PMID:
14981760
15.

Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection.

Guido M, Thung SN, Fattovich G, Cusinato R, Leandro G, Cecchetto A, Cesaro S, Panese P, Rugge M.

Mod Pathol. 1999 Jun;12(6):599-603.

PMID:
10392636
16.

Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection.

Bain C, Fatmi A, Zoulim F, Zarski JP, Trépo C, Inchauspé G.

Gastroenterology. 2001 Feb;120(2):512-24.

PMID:
11159892
17.

Histopathological features of hepatitis C in renal transplant candidates [see comment].

Martin P, Carter D, Fabrizi F, Dixit V, Conrad AJ, Artinian L, Peacock V, Han S, Wilkinson A, Lassman CR, Danovitch G.

Transplantation. 2000 Apr 15;69(7):1479-84.

PMID:
10798774
18.

Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.

Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T, Piccinino F.

Hepatology. 2000 Nov;32(5):1106-10.

PMID:
11050062
19.

Effect of schistosomiasis and hepatitis on liver disease.

Halim AB, Garry RF, Dash S, Gerber MA.

Am J Trop Med Hyg. 1999 Jun;60(6):915-20.

PMID:
10403320
20.

Hepatitis C virus--T-cell responses and viral escape mutations.

Petrovic D, Dempsey E, Doherty DG, Kelleher D, Long A.

Eur J Immunol. 2012 Jan;42(1):17-26. doi: 10.1002/eji.201141593. Epub 2011 Nov 28. Review.

Supplemental Content

Support Center